Skip to content

Cell Source, Inc.

CLCS· OTCCore metricsCIK 1569340

Pharmaceutical preparations552 peers

Close
Sep 17, 2026 · -24.14%
Market cap
$29.90M
67.95M shares
Filings
139
—
—
—
-$1.48M
Q1 2025N/M FY24 yoy
-$998.59K
Q1 2025N/M FY24 yoy
-$3.12M
FY 2014derivedN/M FY14 yoy
-$0.04
Q1 2025N/M FY24 yoy
$1.24K
Q1 2025+236.1% FY24 yoy
$29.90M
—
—
—
—
—

Price

$0.4426.67%$0.16since Jan 13, 2026
Sep 17, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$1.94MFY 2022
$2.46M0FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022
PeriodEndedValueKindSource trail
FY 20222022-12-31$1,938,173reported
FY 20212021-12-31$1,273,352reported
FY 20202020-12-31$834,943reported
FY 20192019-12-31$2,457,051reported
FY 20182018-12-31$274,937reported
FY 20172017-12-31$637,318reported
FY 20162016-12-31$554,185reported
FY 20152015-12-31$392,925reported
FY 20142014-12-31$806,157reported
FY 20132013-12-31$351,513reported

Pharmaceutical preparations

Cell Source, Inc. is the 364th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Cell Source, Inc. · CIK 1569340 · Engraved from SEC EDGAR